Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
Poli A, Wang J, Domingues O, Planagumà J, Yan T, Rygh CB, Skaftnesmo KO, Thorsen F, McCormack E, Hentges F, Pedersen PH, Zimmer J, Enger PØ, Chekenya M.
Poli A, et al. Among authors: mccormack e.
Oncotarget. 2013 Sep;4(9):1527-46. doi: 10.18632/oncotarget.1291.
Oncotarget. 2013.
PMID: 24127551
Free PMC article.